PRISM MarketView announces that Cardiol Therapeutics (CRDL) has been added to the PRISM Emerging Biotech Index. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on CRDL: Cardiol Therapeutics Inc. (CRDL) Q3 Earnings Cheat Sheet Cardiol Therapeutics Expands Trials for Heart Treatment Cardiol Therapeutics Raises $15.5 Million in Offering Cardiol Therapeutics Secures $13.5M in Public Offering Cardiol Therapeutics 8.44M share Secondary priced at $1.60